This study investigates pancreatic ductal adenocarcinoma. It focuses on individuals at high risk or clinically suspicious for this condition.
The study evaluates the effectiveness of a non-invasive blood test in identifying early-stage pancreatic cancer. It looks at the safety and accuracy of this method compared to current standard practices.
- Who can participate: Adults 18 years and older who meet specific risk criteria for pancreatic cancer can participate. Participants must be able to consent and provide a blood sample.
- Study details: Participants will undergo blood tests using an investigational assay. This study involves minimal risk and includes a non-invasive procedure.
- Study timelines: The study will last 3 years with a 2-year follow-up.
How understandable was the trial content above?
Hard to understand
Easy to understand